We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




White Blood Cell Help Define Pediatric Urinary Tract Infections

By LabMedica International staff writers
Posted on 25 Mar 2021
Print article
Image: White blood cells in the urine of a patient with bacteriuria pyuria, a urinary tract infection. The cells have lobed nuclei and refractile cytoplasmic granules (Photo courtesy of University of Utah Medical School).
Image: White blood cells in the urine of a patient with bacteriuria pyuria, a urinary tract infection. The cells have lobed nuclei and refractile cytoplasmic granules (Photo courtesy of University of Utah Medical School).
Urinary tract infections account for up to 7% of fevers in children up to 24 months old and are a common driver of hospital emergency room visits. These bacterial infections in infants and toddlers can be difficult to diagnose because their symptoms are similar to other fever-causing conditions.

If a diagnosis is delayed, a UTI can develop into a serious infection that can cause lasting consequences. For example, UTI-related kidney scarring has been linked with hypertension and chronic kidney disease later in life. To diagnose a UTI, doctors must culture a urine sample and wait for it to grow telltale bacteria in a petri dish containing nutrients. However, this process can take up to two days, delaying treatment.

Pediatricians and their colleagues at UT Southwestern Medical Center (Dallas, TX, USA) carried out a retrospective cross-sectional study of children less than 24 months of age evaluated in the emergency department for suspected UTI with paired urinalysis and urine culture during a 6-year period. The primary outcome was positive urine culture result and culture thresholds. Test characteristics for microscopic pyuria cut points and positive leukocyte esterase (LE) were calculated across three urine specific gravity groups: low <1.011, moderate 1.011 to 1.020, and high >1.020.

The team reported that of the total 24,171 patients analyzed, urine culture result was positive in 2,003 (8.3%). They used the urine's specific gravity and found that optimal white blood cell (WBC) cutoffs per high-power field (HPF) were three (positive likelihood ratio [LR+] 10.5; negative likelihood ratio [LR−] 0.12) at low, six (LR+ 12; LR− 0.14) at moderate, and eight (LR+ 11.1; LR− 0.35) at high urine concentrations. Likelihood ratios for small positive LE from low to high urine concentrations (LR+ 25.2, LR− 0.12; LR+ 33.1, LR− 0.15; LR+ 37.6, LR− 0.41) remained excellent.

Shahid Nadeem, MD, an assistant professor of pediatrics and lead author of the study, said, “For each of these concentration groups, leukocyte esterase remained constant, suggesting that it's a good trigger for analyzing urine for the presence of white blood cells. Knowing how many white blood cells tend to be present in urine samples at different concentrations in children with UTIs could help physicians start treating these infections before they receive urine culture results, giving relief to patients and their parents and preventing complications.”

The authors concluded that the optimal pyuria cut point in predicting positive urine culture results changes with urine concentration in young children. Pyuria thresholds of three WBCs per HPF at low urine concentrations whereas eight WBCs per HPF at high urine concentrations have optimal predictive value for UTI. Positive LE is a strong predictor of UTI regardless of urine concentration. The study was published in the February 2021 issue of the journal Pediatrics.

Related Links:
UT Southwestern Medical Center

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Respiratory QC Panel
Assayed Respiratory Control Panel
New
Mumps Virus Test
ZEUS ELISA Mumps IgG Test System

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.